- 2-CYCLOPROPYL-THIAZOLE DERIVATIVES
-
The invention relates to selected 2-cyclopropyl-thiazole derivatives of the formula (I) wherein B, Y and R1 are as described in the description; to salts and especially pharmaceutically acceptable salts thereof, and to the use of such compounds use as med
- -
-
Page/Page column 25
(2010/09/07)
-
- 3-AZA-BICYCLO[3.1.0]HEXANE DERIVATIVES
-
The invention relates to 3-aza-bicyclo[3.1.0]hexane derivatives of formula (I) wherein A, B, n, X, and R1 are as described in the description, and salts thereof, and their use as orexin receptor antagonists.
- -
-
Page/Page column 46
(2010/02/17)
-
- 3-AZA-BICYCLO[3.3.0]OCTANE COMPOUNDS
-
The invention relates to 3-aza-bicyclo[3.3.0]octane derivatives of the formula (I) wherein R1, R2, R3, and A are as described in the description and their use as orexin receptor antagonists.
- -
-
Page/Page column 47
(2009/03/07)
-
- TRANS-3-AZA-BICYCLO[3.1.0]HEXANE DERIVATIVES
-
The invention relates to novel trans-3-aza-bicyclo[3.1.0]hexane derivatives of formula (I), wherein A, B, n and R1 are as described in the description, and to the use of such compounds, or of pharmaceutically acceptable salts of such compounds, as medicaments, especially as orexin receptor antagonists.
- -
-
Page/Page column 81
(2009/03/07)
-
- 2-AZA-BICYCLO[3.1.0]HEXANE DERIVATIVES
-
The invention relates to novel 2-aza-bicyclo[3.1.0]hexane derivatives of Formula (I) wherein A, B, n and R1 are as described in the description, and to the use of such compounds, or of pharmaceutically acceptable salts of such compounds, as medicaments, especially as orexin receptor antagonists.
- -
-
Page/Page column 70
(2008/12/07)
-
- 2-CYCLOPROPYL-THIAZOLE DERIVATIVES
-
The invention relates to selected 2-cyclopropyl-thiazole derivatives of the formula (I) wherein B, Y and R1 are as described in the description; to salts and especially pharmaceutically acceptable salts thereof, and to the use of such compounds use as medicaments, especially as orexin receptor antagonists.
- -
-
Page/Page column 51
(2009/01/20)
-